L

LivaNova PLC
D

LIVN

45.760
USD
-0.91
(-1.95%)
مغلق
حجم التداول
15,402
الربح لكل سهم
2
العائد الربحي
-
P/E
-11
حجم السوق
2,495,095,620
أصول ذات صلة
BAX
BAX
-0.760
(-2.42%)
30.610 USD
BDX
BDX
-2.215
(-1.27%)
172.245 USD
BSX
BSX
1.190
(1.21%)
99.750 USD
EW
EW
-0.720
(-0.95%)
75.170 USD
ISRG
ISRG
-0.86
(-0.17%)
511.99 USD
MTD
MTD
-33.18
(-2.79%)
1,155.03 USD
PODD
PODD
0.89
(0.29%)
304.58 USD
SYK
SYK
-3.14
(-0.83%)
377.30 USD
TMO
TMO
-12.61
(-3.04%)
402.69 USD
المزيد
الأخبار المقالات

العنوان: LivaNova PLC

القطاع: Healthcare
الصناعة: Medical Devices
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.